Los Blancos will look to make it another memorable European night in Lisbon.

The UEFA Champions League league phase is nearing its end, and the race for positions is heating up. With 18 matches kicking ...

Prologis (PLD) outlook: tightening logistics, strong rent growth, and data center/energy expansion support upside to 2026 FFO ...

Roche’s dual GLP-1/GIP receptor agonist has been tied to 22.5% weight loss at 48 weeks, validating the company’s decision to move the asset into phase 3 studies this quarter.

Nikola Jokić won't rush to preserve his NBA award eligibility. He knows what the Nuggets are capable of and is making the ...

Investing.com -- Intellia Therapeutics (NASDAQ:NTLA) stock soared 20% Tuesday after the U.S. Food and Drug Administration (FDA) lifted a clinical hold on the company’s MAGNITUDE-2 Phase 3 trial for ...

A new Fisher Lift Station is replacing the existing, outdated station and increasing its capacity to serve development in ...

Looking at Energy Transfer as it stands right now, it appears very attractive. Notably, if you add the 7% yield to the 3% ...

Hailing from Kazakhstan, this season has seen Kairat Almaty make their Champions League debut. After winning the Kazakhstan ...

A $3.5 million wastewater project in the city of Post Falls with multiple phases is underway to replace the current Fisher ...

BERLIN, Jan 27 (Reuters) - Swiss pharmaceutical firm Roche said on Tuesday that a phase II clinical trial of its experimental ...

Two intriguing corporations to consider now are Viking Therapeutics ( VKTX 0.38%) and BioNTech ( BNTX +1.02%). These biotech ...